Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research

Proteomics

Volumn 12, Issue 13, 2012, Pages 2067-2077

  Asplund, Anna ^a   Edqvist, Per Henrik D ^a   Schwenk, Jochen M ^b   Pontén, Fredrik ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Antibody; Biomarker; Biomedicine; Cancer; Protein profile; Tissue staining

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; MESSENGER RNA; PROTEOME;

ARTICLE; ATLAS; CANCER RESEARCH; COMPARATIVE STUDY; GENOME; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEOMICS;

ANTIBODIES; DATABASES, PROTEIN; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84864001338     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100504     Document Type: Article

References (46)

1. Uhlen, M., Bjorling, E., Agaton, C., Szigyarto, C. A. et al., A Human Protein Atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics 2005, 4, 1920-1932.
2. Barbe, L., Lundberg, E., Oksvold, P., Stenius, A. et al., Toward a confocal subcellular atlas of the human proteome. Mol. Cell Proteomics 2008, 7, 499-508.
3. Lundberg, E., Uhlen, M., Creation of an antibody-based subcellular protein atlas. Proteomics 2010, 10, 3984-3996.
4. Mulder, J., Bjorling, E., Jonasson, K., Wernerus, H. et al., Tissue profiling of the mammalian central nervous system using human antibody-based proteomics. Mol. Cell Proteomics 2009, 8, 1612-1622.
5. Ponten, F., Gry, M., Fagerberg, L., Lundberg, E. et al., A global view of protein expression in human cells, tissues, and organs. Mol. Syst. Biol. 2009, 5, 337-346.
6. Ponten, F., Schwenk, J. M., Asplund, A., Edqvist, P. H., The Human Protein Atlas as a proteomic resource for biomarker discovery. J. Int. Med. 2011, 270, 428-446.
7. Berglund, L., Bjorling, E., Oksvold, P., Fagerberg, L. et al., A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol. Cell Proteomics 2008, 7, 2019-2027.
8. Taussig, M. J., Stoevesandt, O., Borrebaeck, C. A., Bradbury, A. R. et al., ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat. Methods 2007, 4, 13-17.
9. Haab, B. B., Paulovich, A. G., Anderson, N. L., Clark, A. M. et al., A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report. Mol. Cell Proteomics 2006, 5, 1996-2007.
10. Colwill, K., Graslund, S., A roadmap to generate renewable protein binders to the human proteome. Nat. Methods 2011, 8, 551-558.
11. Uhlen, M., Ponten, F., Antibody-based proteomics for human tissue profiling. Mol. Cell Proteomics 2005, 4, 384-393.
12. Wolff, A. C., Hammond, M. E., Schwartz, J. N., Hagerty, K. L. et al., American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol. 2007, 25, 118-145.
13. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M. et al., Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Medicine 1998, 4, 844-847.
14. Kampf, C., Andersson, A. C., Wester, K., Bjorling, E. et al., Antibody-based tissue profiling as a tool for clinical proteomics. Clin. Proteomics 2004, 1, 285-299.
15. Rockberg, J., Lofblom, J., Hjelm, B., Uhlen, M., Stahl, S., Epitope mapping of antibodies using bacterial surface display. Nat. Methods 2008, 5, 1039-1045.
16. Hjelm, B., Forsstrom, B., Igel, U., Johannesson, H. et al., Generation of monospecific antibodies based on affinity capture of polyclonal antibodies. Protein Sci. 2011, 20, 1824-1835.
17. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E. et al., Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
18. Blokzijl, A., Friedman, M., Ponten, F., Landegren, U., Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine. J. Int. Med. 2010, 268, 232-245.
19. Andersson, A. C., Stromberg, S., Backvall, H., Kampf, C. et al., Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics. J. Histochem. Cytochem. 2006, 54, 1413-1423.
20. Stromberg, S., Bjorklund, M. G., Asplund, C., Skollermo, A. et al., A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. Proteomics 2007, 7, 2142-2150.
21. Lundberg, E., Gry, M., Oksvold, P., Kononen, J. et al., The correlation between cellular size and protein expression levels-normalization for global protein profiling. J. Proteomics 2008, 71, 448-460.
22. Chen, G., Gharib, T. G., Huang, C. C., Taylor, J. M. et al., Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell Proteomics 2002, 1, 304-313.
23. Gry, M., Rimini, R., Stromberg, S., Asplund, A. et al., Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 2009, 10, 365.
24. A gene-centric human proteome project. HUPO-the Human Proteome organization. Mol. Cell Proteomics 2010, 9, 427-429.
25. Legrain, P., Aebersold, R., Archakov, A., Bairoch, A. et al., The human proteome project: current state and future direction. Mol. Cell Proteomics 2011, 10, M111.009993.
26. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T. et al., Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437, 1173-1178.
27. Uhlen, M., Oksvold, P., Algenas, C., Hamsten, C. et al., Antibody-based protein profiling of the human chromosome 21. Mol. Cell Proteomics 2011, 11, M111.013458.
28. Brennan, D. J., O'Connor, D. P., Rexhepaj, E., Ponten, F., Gallagher, W. M., Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat. Rev. Cancer 2010, 10, 605-617.
29. Carr, K. M., Rosenblatt, K., Petricoin, E. F., Liotta, L. A., Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy. Hum. Genomics 2004, 1, 134-140.
30. Stricker, T., Catenacci, D. V., Seiwert, T. Y., Molecular profiling of cancer-the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic. Semin. Oncol. 2011, 38, 173-185.
31. Magnusson, K., De Wit, M., Brennan, D. J., Johnson, L. B. et al., SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am. J. Surg. Pathol. 2011, 35, 937-948.
32. Swerdlow, S. H., Campo, E., Lee Harris, N., Jaffe, E. S., Pileri, S. A., Stein, H., Thiele, J., Vardiman, J. M., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer (IARC), Lyon, France 2008.
33. Zola, H., Swart, B., Nicholson, I., Voss, E., Leukocyte and Stromal Cell Molecules: The CD Markers, John Wiley & sons, Inc, Hoboken, NJ 2007.
34. Alymani, N. A., Smith, M. D., Williams, D. J., Petty, R. D., Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation. Eur. J. Cancer 2010, 46, 869-879.
35. Mulrane, L., Rexhepaj, E., Penney, S., Callanan, J. J., Gallagher, W. M., Automated image analysis in histopathology: a valuable tool in medical diagnostics. Expert Rev. Mol. Diagn. 2008, 8, 707-725.
36. Rexhepaj, E., Brennan, D. J., Holloway, P., Kay, E. W. et al., Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res. 2008, 10, R89.
37. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T. et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98, 10869-10874.
38. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T. et al., Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 2003, 100, 8418-8423.
39. Reis-Filho, J. S., Pusztai, L., Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 2011, 378, 1812-1823.
40. Kiflemariam, S., Andersson, S., Asplund, A., Ponten, F. et al., Scalable in situ hybridization on tissue arrays for validation of novel cancer and tissue-specific biomarkers. PLoS one 2012, 7, e32927.
41. Hu, S., Loo, J. A., Wong, D. T., Human body fluid proteome analysis. Proteomics 2006, 6, 6326-6353.
42. Schwenk, J. M., Igel, U., Neiman, M., Langen, H. et al., Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays. Mol. Cell Proteomics 2010, 9, 2497-2507.
43. Salazar, R., Roepman, P., Capella, G., Moreno, V. et al., Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J. Clin. Oncol. 2011, 29, 17-24.
44. Paik, S., Shak, S., Tang, G., Kim, C. et al., A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 2004, 351, 2817-2826.
45. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D. et al., Expression profiling predicts outcome in breast cancer. Breast Cancer Res. 2003, 5, 57-58.
46. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H. et al., A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002, 347, 1999-2009.